BAD Cancer Research Results
BAD, BCL2 associated agonist of cell death: Click to Expand ⟱
| Source: |
| Type: |
BCL2 associated agonist of cell death (BAD) protein is a pro-apoptotic member of the Bcl-2 gene family.
Expression of the BAD is associated with the development and progression of cancer.
|
Scientific Papers found: Click to Expand⟱
*AntiCan↑, *antiOx↑, *hepatoP↑, *neuroP↑, *ROS↓, Ca+2↑, ROS↑, BAX↑, Casp3↑, Casp9↑, Cyt‑c↑, MMP↓, Mcl-1↓, PI3K↓, Akt↓, mTOR↓, BAD↓, ERK↓, MEK↓, DR5↑, Fas↑, TumMeta↓, EMT↓, SMAD4↓, TGF-β↓, MMP9↓, MMP2↓, HIF-1↓, 12LOX↓,
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27↑, P53↑,
| - |
in-vitro, |
AD, |
HT22 |
|
|
|
- |
in-vivo, |
AD, |
NA |
|
|
|
*ROS↓, *Ca+2↓, *BAX↓, *BAD↓, *Casp3↓, *cognitive↑, *memory↑, *Aβ↓, *GPx↑, *SOD↑, *ChAT↑, *Ach↑, *AChE↓, *ROS↓, *p‑Akt↑, *p‑mTOR↑, *neuroP↑,
14-3-3 proteins↓, p‑BAD↓, p‑Akt↓, Akt↓, cl‑Casp9↑, cl‑PARP↑,
Apoptosis↑, TumCCA↑, p‑Akt↓, Akt↓, Bcl-2↓, p‑BAD↓, BAD↑, cl‑PARP↑, ROS↑, HSP27↑, Beclin-1↑, p62↑, GPx1↓, GPx4↓,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
SDC1↑, p‑PCK1↓, Akt↓, BAD↓,
BAD↓, cl‑PARP↑, Casp7↑, IκB↓, Ki-67↓, VEGF↓, EGFR↓, FGF↓, TGF-β↓, TNF-α↓, SCF↓, Bax:Bcl2↑, NF-kB↓, chemoP↑, ChemoSen↑, TumVol↓,
AntiCan↑, angioG↓, ChemoSen↑, RadioS↑, VEGF↓, MMP2↓, MMP9↓, Telomerase↓, TrxR↓, ERK↓, HSP90↓, ROS↑, SIRT1↑, survivin↓, cFLIP↓, Casp3↑, Casp8↑, Casp9↑, BAD↓, BID↓, Bcl-2↓, BAX↑, STAT3↓, hTERT/TERT↓, NF-kB↓, Myc↓, Hif1a↓, FOXD3↑, BioAv↓, BioAv↑, P53↑, eff↓, OCR↓, MMP↓, PI3K↓, Akt↓, BBB↑, TumCG↓, TumMeta↓, BioAv↑,
TumCP↓, p‑CHK1↓, Ca+2↑, Casp3↓, Casp7↓, p‑BAD↓, ChemoSen↑,
*BAD↓, *BAX↓, *Casp3↓, *Bcl-xL↑, *p‑Akt↑, *MMP9↓, *p‑ERK↑, *HIF-1↓, *ROS↓, *VEGF↑, *Ca+2↓, *SOD↑, *IL2↑, *p38↑, *HSP70/HSPA5↑, *Apoptosis↓, *ROS↓, *NO↓,
| - |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vitro, |
Pca, |
PrEC |
|
|
|
- |
in-vitro, |
Pca, |
YPEN-1 |
|
|
|
- |
in-vitro, |
Pca, |
HCT116 |
|
|
|
Casp8↑, Casp9↑, PARP↑, BAD↓, BAX↑, PI3K/Akt↓, Cyt‑c↑, selectivity↑,
AR↓, PI3K/Akt↓, miR-21↓, STAT3↓, BAD↓, PRAS40↓, GSK‐3β↓, PSA↓, NKX3.1↑, Bax:Bcl2↑, miR-19b↓, miR-148a↓, AMPKα↓, TumCP↓, chemoPv↑, TumCMig↓,
| - |
in-vitro, |
GC, |
HGC27 |
|
|
|
- |
in-vitro, |
GC, |
NCI-N87 |
|
|
|
AntiTum↑, HOXB-AS1↓, TumCP↓, TumCI↓, Apoptosis↑, BAD↓, Bcl-2↓, cl‑Casp3↑, MMP2↓, E-cadherin↑, N-cadherin↓, ROS↑, NF-kB↓,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GPx1↓, 1, GPx4↓, 1, ROS↑, 4, TrxR↓, 1,
Mitochondria & Bioenergetics ⓘ
BOK↑, 1, MEK↓, 1, MMP↓, 2, OCR↓, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, AMPK↑, 1, p‑PCK1↓, 1, PDK1↓, 1, PI3K/Akt↓, 2, SIRT1↑, 1,
Cell Death ⓘ
14-3-3 proteins↓, 1, Akt↓, 6, p‑Akt↓, 3, APAF1↑, 1, Apoptosis↑, 2, BAD↓, 8, BAD↑, 1, p‑BAD↓, 3, BAX↑, 4, Bax:Bcl2↑, 2, Bcl-2↓, 4, BID↓, 1, BID↑, 1, Casp3↓, 1, Casp3↑, 3, cl‑Casp3↑, 1, Casp7↓, 1, Casp7↑, 2, Casp8↑, 3, Casp9↑, 4, cl‑Casp9↑, 1, cFLIP↓, 1, Cyt‑c↑, 2, DR5↑, 1, FADD↑, 1, Fas↑, 2, FasL↑, 1, hTERT/TERT↓, 1, Mcl-1↓, 2, Myc↓, 1, NAIP↓, 1, p27↑, 1, survivin↓, 1, Telomerase↓, 1, TRAIL↑, 1,
Kinase & Signal Transduction ⓘ
AMPKα↓, 1, FOXD3↑, 1,
Transcription & Epigenetics ⓘ
miR-21↓, 1, tumCV↓, 1,
Protein Folding & ER Stress ⓘ
HSP27↑, 1, HSP90↓, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, p62↑, 1,
DNA Damage & Repair ⓘ
p‑CHK1↓, 1, NKX3.1↑, 1, P53↑, 2, PARP↑, 1, cl‑PARP↑, 3,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, cycE1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, ERK↓, 2, FGF↓, 1, GSK‐3β↓, 1, GSK‐3β↑, 1, HOXB-AS1↓, 1, mTOR↓, 2, PI3K↓, 2, SCF↓, 1, STAT3↓, 2, TumCG↓, 1,
Migration ⓘ
Ca+2↑, 2, E-cadherin↑, 1, Ki-67↓, 1, miR-148a↓, 1, miR-19b↓, 1, MMP2↓, 3, MMP9↓, 2, N-cadherin↓, 1, SDC1↑, 1, SMAD4↓, 1, TGF-β↓, 2, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 3, TumMeta↓, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EGFR↓, 1, HIF-1↓, 1, Hif1a↓, 1, VEGF↓, 2,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
IκB↓, 1, NF-kB↓, 3, PSA↓, 1, TNF-α↓, 1, TNF-α↑, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, ChemoSen↑, 3, eff↓, 1, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
AR↓, 1, EGFR↓, 1, hTERT/TERT↓, 1, Ki-67↓, 1, Myc↓, 1, PSA↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, chemoP↑, 1, chemoPv↑, 1, PRAS40↓, 1, TumVol↓, 1,
Total Targets: 123
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GPx↑, 1, ROS↓, 5, SOD↑, 2,
Cell Death ⓘ
p‑Akt↑, 2, Apoptosis↓, 1, BAD↓, 2, BAX↓, 2, Bcl-xL↑, 1, Casp3↓, 2, p38↑, 1,
Transcription & Epigenetics ⓘ
Ach↑, 1,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↑, 1, p‑mTOR↑, 1,
Migration ⓘ
Ca+2↓, 2, MMP9↓, 1,
Angiogenesis & Vasculature ⓘ
HIF-1↓, 1, NO↓, 1, VEGF↑, 1,
Immune & Inflammatory Signaling ⓘ
IL2↑, 1,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, ChAT↑, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, cognitive↑, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 2,
Total Targets: 29
Scientific Paper Hit Count for: BAD, BCL2 associated agonist of cell death
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:426 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page